Open AccessModulation of the Gut Microbiota during High-Dose Glycerol Monolaurate-Mediated Amelioration of Obesity in Mice Fed a High-Fat Diet
Author(s) -
Minjie Zhao,
Zengliang Jiang,
Hong Cai,
Li Yang,
Qiufen Mo,
Lingli Deng,
Hao Zhong,
Tao Liu,
Hui Zhang,
Jing Kang,
Fengqin Feng
Publication year - 2020
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.00190-20
Subject(s) - metabolome , gut flora , obesity , glycerol , microbiome , transcriptome , biology , antibiotics , food science , microbiology and biotechnology , physiology , metabolomics , endocrinology , biochemistry , bioinformatics , gene expression , gene
Obesity and associated metabolic disorders are worldwide public health issues. The gut microbiota plays a key role in the pathophysiology of diet-induced obesity. Glycerol monolaurate (GML) is a widely consumed food emulsifier with antibacterial properties. Here, we explore the anti-obesity effect of GML (1,600 mg/kg of body weight) in high-fat diet (HFD)-fed mice. HFD-fed mice were treated with 1,600 mg/kg GML. Integrated microbiome, metabolome, and transcriptome analyses were used to systematically investigate the metabolic effects of GML, and antibiotic treatment was used to assess the effects of GML on the gut microbiota.